Mechanisms of the therapeutic effect of Bemitil in neuromuscular diseases
V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov · 1991 · Zh Nevropatol Psikhiatr Im S S Korsakova. 91(9):22–24. PMID 1664607
What does this source report?
Examined lipid peroxidation and erythrocyte-membrane permeability during Bemitil treatment.
- Population and setting
- 21 patients with neuromuscular diseases
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Clinical-trial indexing does not establish randomization or a concurrent control.
- Biochemical changes do not establish durable functional improvement.
- Possible cohort overlap with the 1992 report needs full-text checking.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov. Mechanisms of the therapeutic effect of Bemitil in neuromuscular diseases Zh Nevropatol Psikhiatr Im S S Korsakova. 91(9):22–24. PMID 1664607 1991.
Molekul research summary: https://molekul.io/research/acto-1664607. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry